Group 1 - Sanbo Brain Science (301293.SZ) released its 2024 annual report on April 18, 2025, with 69 institutional investors holding a total of 54.79 million A-shares, accounting for 26.60% of the total share capital [1] - The top ten institutional investors include TBP 3Doctors (HK) Limited, various products from Taikang Life Insurance Co., Ltd., and others, with a combined holding ratio of 25.80%, which decreased by 5.34 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, 61 new public funds were disclosed this period, including Southern CSI 1000 ETF and others, while one public fund, Dongcai Yuanjian Growth Mixed Initiation A, was no longer disclosed [2] - In the insurance capital sector, two insurance funds reduced their holdings compared to the previous quarter, while one new insurance investor was disclosed, namely Taikang Life Insurance Co., Ltd. - Dividend - Personal Dividend - 019L-FH002 [2]

Group 1 - The core point of the news is the performance and structure of the FuGuo Zhongzheng Communication Equipment Theme ETF Initiated Link A, which has seen a decline in value and has a specific holder composition [1][3]. - As of April 17, 2024, the fund's net value is 1.11 yuan, with a cumulative decline of 3.09% over three trading days [1]. - The fund was established in August 2024 with a total size of 0.14 billion yuan and has achieved a cumulative return of 10.72% since inception [1]. Group 2 - The fund's holder structure indicates that institutional investors hold 0.10 billion shares, accounting for 93.38% of the total shares, while individual investors hold 0.01 billion shares, making up 6.62% [1]. - The top three holdings of the fund as of December 31, 2024, account for a total of 3.27%, with the largest holding being 24 National Bond 09 at 2.18% [3]. Group 3 - The current fund manager, Su Huaqing, has a background in quantitative research and has held various managerial positions since joining FuGuo Fund Management in June 2022 [2]. - Su Huaqing has been appointed as the fund manager for multiple funds, including the FuGuo Zhongzheng Communication Equipment Theme ETF Initiated Link Fund starting from June 2024 [2].

据了解，富国创业板中盘200ETF发起式联接A成立于2024年2月，基金规模0.18亿元，成立来累计收益 率15.40%。从持有人结构来看，截至2024年末，富国创业板中盘200ETF发起式联接A的基金机构持有 0.10亿份，占总份额的65.07%，个人投资者持有0.05亿份，占总份额的34.93%。 公开信息显示，现任基金经理金泽宇先生:博士,自2018年7月加入富国基金管理有限公司,历任助理定量 研究员、初级定量研究员、定量研究员;现任富国基金量化投资部定量基金经理。自2022年07月起任富 国中证1000交易型开放式指数证券投资基金基金经理;自2022年11月起任富国中证1000交易型开放式指 数证券投资基金联接基金基金经理;自2023年09月起任富国中证2000交易型开放式指数证券投资基金基 金经理;自2023年12月起任富国创业板中盘200交易型开放式指数证券投资基金基金经理;自2024年02月 起任富国创业板中盘200交易型开放式指数证券投资基金发起式联接基金基金经理;自2024年05月起任富 国沪深300交易型开放式指数证券投资基金基金经理;自2024年05月起任富国中证红利低波动交易型开放 式 ...

截止2024年12月31日，富国医疗产业混合发起式A前十持仓占比合计70.95%，分别为：联影医疗 （9.19%）、鱼跃医疗（9.03%）、惠泰医疗（8.96%）、迈瑞医疗（8.32%）、新产业（7.71%）、爱博 医疗（7.62%）、稳健医疗（5.76%）、羚锐制药（4.90%）、艾德生物（4.77%）、开立医疗 （4.69%）。 来源：金融界 4月17日，富国医疗产业混合发起式A（021450）下跌0.45%，最新净值0.96元，连续3个交易日下跌， 区间累计跌幅2.21%。 据了解，富国医疗产业混合发起式A成立于2024年5月，基金规模0.11亿元，成立来累计收益率-3.86%。 从持有人结构来看，截至2024年末，富国医疗产业混合发起式A的基金机构持有0.10亿份，占总份额的 94.23%，个人投资者持有0.01亿份，占总份额的5.77%。 公开信息显示，现任基金经理孙笑悦女士:硕士,曾任易唯思(Evalueserve)咨询公司医药分析师助理,国金 证券股份有限公司上海投资咨询分公司医药资深分析师;自2018年8月加入富国基金管理有限公司,历任 高级行业研究员、权益基金经理;现担任富国基金权益投资部高 ...

Company Overview - Nanguo Real Estate (002305) has experienced a decline for four consecutive trading days, with a cumulative drop of -10.64% [1] - The company was established in 1998 and became the first commercial real estate company to go public after the IPO restart in 2009 on the Shenzhen Stock Exchange [1] Shareholder Information - Two funds under the management of Fortune Fund have entered the top ten shareholders of Nanguo Real Estate, specifically Fortune Quality Growth 6-Month Holding Mixed A and Fortune New Vitality Flexible Allocation Mixed A, both of which reduced their holdings in the fourth quarter of last year [1] - Fortune Quality Growth 6-Month Holding Mixed A has a year-to-date return of 11.57%, ranking 300 out of 4559 in its category, while Fortune New Vitality Flexible Allocation Mixed A has a year-to-date return of 10.28%, ranking 107 out of 2308 [1] Fund Manager Profile - The fund manager for both Fortune Quality Growth 6-Month Holding Mixed A and Fortune New Vitality Flexible Allocation Mixed A is Wu Dongdong, who has a background in mechanical engineering and has held various research positions in the finance industry since 2016 [5][6] - Wu Dongdong has been managing the Fortune Quality Growth 6-Month Holding Mixed A since February 28, 2022, and the Fortune New Vitality Flexible Allocation Mixed A since February 23, 2023 [6]

低空经济作为新兴产业，迎来全新发展机遇。 据新华社测算，2023年我国低空经济规模已突破5000亿元，并预计到2030年这一数字将达到2万亿元，呈现强 劲的增长势头，预计七年复合年增长率将达到22%。 政策红利持续释放，推动产业发展。 2023年12月，中央经济工作会议明确将低空经济提升为战略性新兴产业；同时，2024年两会期间，国务院政府工作报 告中也强调了低空经济作为新增长引擎的重要地位，进一步推动了地方政府的响应与行动。从地方层面来看，今年以来，全国已有近30个省份将发展低空经 济写入政府工作报告或出台相关政策。 国证通用航空产业指数：低空经济"含金量"高。 指数选取50只沪深北交易所通用航空产业相关上市公司证券作为指数样本，涵盖低空经济全产业链，国防 军工权重占比近60%，兼具军民融合属性。 长期收益优于创业板指，历史业绩反弹弹性较大。 Wind数据显示，截至今年4月3日，自2012年12月28日以来，通用航空指数的累计涨幅为213.03%，相对 创业板指数的超额收益为17.79%，同期国证军工指数收益率为121.93%，超额收益达91.10%。另外，2024年年初以来市场上行期，反弹市场的业绩表现优 ...

随着2025年一季度收官，富国基金管理有限公司（以下简称"富国基金"）凭借专业的资产管理能力和长 期稳健的投资业绩，为投资者交出亮眼成绩单。截至2025年3月31日，富国基金资产管理规模超1.62万 亿元，其中，公募资产管理规模达1.06万亿元，公募基金产品数量超370只，服务机构及个人投资者用 户数量达1.32亿户。 依托权益、固收、量化三大核心投研平台的协同效应，富国基金旗下相关产品长期业绩表现突出。在主 动权益投资领域，富国基金坚持"深入研究、自下而上、尊重个性、长期回报"的投资理念，展现出卓越 的长期投资能力。中国银河（601881）证券数据显示，截至2025年3月31日，富国基金旗下主动权益类 产品近二十年累计收益率达953.86%，位列行业第四，其中，有3只基金实现十倍回报，46只基金净值 增长率超过100%。 本报讯 （记者昌校宇） 作为国内量化投资领域的先行者，富国基金量化团队成立16年来，通过前瞻布局与持续创新，已构建覆 盖多资产、多策略的产品矩阵。资讯数据显示，截至2025年3月31日，富国基金量化团队公募资产管理 规模超2400亿元，其中，ETF规模超1900亿元。近年来，ETF迎来爆发 ...

Group 1 - The core viewpoint of the news is that as of April 8, 2025, institutional investors hold a significant majority of Heatway Co., Ltd.'s A-shares, with a total holding of 363 million shares, representing 90.21% of the total share capital [1] - The top ten institutional investors collectively hold 89.90% of the shares, with a slight decrease of 0.18 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, two public funds reduced their holdings compared to the previous quarter, including Huaxia CSI 1000 ETF and Southern CSI 1000 ETF, with a slight decline in the holding ratio [2] - A total of 124 new public funds were disclosed this period, including notable funds such as the Fortune CSI 1000 Index Enhanced (LOF) A and GF CSI 1000 ETF [2] - In terms of foreign investment, one new foreign institution was disclosed this period, namely Hong Kong Central Clearing Limited, while Goldman Sachs and Morgan Stanley were not disclosed this quarter [2]

1. Report Industry Investment Rating - No industry investment rating is provided in the report. 2. Core Viewpoints of the Report - The healthcare industry is promising with AI assistance and policy support. With the government's emphasis on the "AI +" initiative and related policies, and the increasing demand and supply in the healthcare market, the industry is undergoing significant changes, presenting more investment opportunities [3][7][14]. - The Hang Seng Hong Kong Stock Connect Healthcare Index has investment value. It has a large capacity and wide market - value coverage, high stock concentration, and currently has a low valuation with room for repair [18][21][34]. - The China Universal Hang Seng Hong Kong Stock Connect Healthcare ETF and its linked fund are good investment vehicles. The ETF has excellent tracking performance, and the linked fund can achieve returns similar to the index by investing in the target ETF [3][37][39]. 3. Summary by Directory 3.1 AI Assistance, Policy Support, and a Promising Future for the Healthcare Industry - The healthcare industry aims to ensure national health, covering multiple fields such as drugs, biotechnology, and medical services. It has significant technological and people - related characteristics [7]. - From the demand side, China's monthly medical treatment volume and annual health expenditure are increasing, indicating an expanding medical service market and growing health consumption. In 2024, the per - capita healthcare consumption expenditure was 2,547 yuan, a 3.6% increase, accounting for 9.0% of per - capita consumption expenditure [7]. - From the supply side, China's medical device exports have remained at a high level since 2020, demonstrating the competitiveness of Chinese medical enterprises in the global market [10]. - AI technology is being increasingly applied in the healthcare field, and policies are promoting the development of "AI + medicine and health", which will drive the industry into a new era of "precision, universal access, and intelligence" [14]. - The government supports the development of innovative drugs, and local governments are taking corresponding actions, which will promote the high - quality development of the chemical pharmaceutical field [14]. 3.2 Investment Value of the Hang Seng Hong Kong Stock Connect Healthcare Index 3.2.1 Hang Seng Theme Index Series Compilation Plan - The Hang Seng Hong Kong Stock Connect Healthcare Index is issued by the Hang Seng Index Company, with a base date of December 31, 2014, and a base point of 3,000. Its 40 component stocks are selected from Hong Kong - listed companies engaged in healthcare - related businesses through the Hong Kong Stock Connect, and are weighted by free - float market value [18]. - The sample selection method includes classifying securities by industry, excluding companies with low R & D expenditure ratios, selecting the top 40 by market value, and adjusting the component stocks semi - annually [19]. 3.2.2 Component Stock Market - Value Distribution: Large Capacity and Wide Coverage - As of April 2, 2025, the total market value of the 40 component stocks of the index is HK$1.63 trillion, and the total free - float market value is HK$0.69 trillion, accounting for 2.99% and 3.34% of the Hang Seng Composite Index respectively. The index has a large capacity and wide market - value coverage [21]. - There are both leading enterprises with a market value of over HK$100 billion and many companies with a market value of less than HK$20 billion. The number of companies with a total market value of less than HK$50 billion is the largest, and the companies with the largest total market value are BeiGene and WuXi AppTec [21]. - The free - float market value is more concentrated below HK$10 billion, and the company with the largest free - float market value is BeiGene [24]. 3.2.3 High Stock Concentration - As of April 2, 2025, the top ten component stocks of the index account for 70.68% of the total weight, with the highest weight of a single stock reaching 13.99%. All the top ten stocks belong to the pharmaceutical and biological industry, covering various sub - industries such as chemical pharmaceuticals, biological products, medical devices, and medical services [27]. - BeiGene, with a weight of 13.99%, is expected to turn a profit in 2025 according to market forecasts [27][28]. 3.2.4 Index Valuation and Performance: Weak Performance Since 2024 and Low Valuation - As of April 2, 2025, among the 40 component stocks, 18 have a negative PE, and 17 of the remaining stocks have a current PE percentile below the 50% level in the past ten years, with 11 below the 30% level. The healthcare sector currently has a low valuation and room for repair [34]. - Historically, the index has generally outperformed the Hang Seng Composite Index. Although its performance has been poor since 2024, the trend is expected to improve with the development of AI in 2025. In an uncertain global environment, the pharmaceutical sector has relatively weak trade - relatedness and growing demand, so there is potential for repair [34]. 3.3 China Universal Hang Seng Hong Kong Stock Connect Healthcare ETF and Its Linked Fund 3.3.1 China Universal Hang Seng Hong Kong Stock Connect Healthcare ETF - The ETF (fund code: 159506) was listed on July 3, 2023, with Tian Ximeng as the fund manager. It closely tracks the Hang Seng Hong Kong Stock Connect Healthcare Index, with a tracking error of 1.67% in the past year. The management fee is 0.50% and the custody fee is 0.10% [37]. 3.3.2 China Universal Hang Seng Hong Kong Stock Connect Healthcare ETF Linked Fund - The linked fund (A - class fund code: 020110, C - class fund code: 020111) was established on December 5, 2023, also managed by Tian Ximeng. It invests in the target ETF to track the index and achieve returns similar to the index. The management fee is 0.50% and the custody fee is 0.10% [39]. 3.4 Appendix 3.4.1 Fund Manager Introduction - China Universal Fund Management Co., Ltd. was established in Beijing in 1999, one of the first ten fund management companies approved by the China Securities Regulatory Commission. It has branches in multiple cities and foreign - capital participation. It has rich investment management experience and provides professional fund investment services [40]. 3.4.2 Fund Manager Profile - Tian Ximeng, a master's degree holder, joined China Universal Fund in May 2017. He has held various positions and is currently a quantitative fund manager in the Quantitative Investment Department of the company [41].

Report Summary 1. Market Overview - The Shanghai Composite Index rose 1.58% to close at 3145.55 points, the Shenzhen Component Index rose 0.64% to close at 9424.68 points, and the ChiNext Index rose 1.83% to close at 1840.31 points. The total trading volume of A-shares in the two markets was 1.6536 trillion yuan. The top-performing sectors were agriculture, forestry, animal husbandry and fishery (7.81%), commerce and retail (3.44%), and food and beverages (3.37%), while the worst-performing sectors were electronics (-1.69%), automobiles (-1.63%), and communications (-0.93%) [2][7]. 2. Stock ETFs - The top trading volume stock ETFs were Huatai-PineBridge CSI 300 ETF (up 0.95% with a discount rate of 1.45%), Southern CSI 500 ETF (up 0.62% with a discount rate of 0.56%), and E Fund CSI 300 ETF (up 2.26% with a discount rate of 1.41%) [3][8]. 3. Bond ETFs - The top trading volume bond ETFs were Penghua ChinaBond 30-Year Treasury Bond ETF (down 0.70% with a discount rate of -0.57%), Bosera CSI Convertible Bond and Exchangeable Bond ETF (up 1.06% with a discount rate of 0.61%), and Fullgoal ChinaBond 7-10 Year Policy Financial Bond ETF (down 0.40% with a discount rate of -0.19%) [4][10]. 4. Gold ETFs - Gold AU9999 rose 0.49% and Shanghai Gold rose 0.30%. The top trading volume gold ETFs were HuaAn Gold ETF (up 0.70% with a discount rate of 0.93%), E Fund Gold ETF (up 0.54% with a discount rate of 0.83%), and Bosera Gold ETF (up 0.61% with a discount rate of 0.90%) [13]. 5. Commodity Futures ETFs - The top trading volume commodity futures ETFs were ChinaAMC Feed Soybean Meal Futures ETF (up 3.70% with a discount rate of 2.62%), Dacheng Nonferrous Metals Futures ETF (up 0.63% with a discount rate of -1.45%), and CCB ESG Zhengzhou Commodity Exchange Energy and Chemical Futures ETF (up 1.20% with a discount rate of -3.12%) [14]. 6. Cross-Border ETFs - The previous trading day, the Dow Jones Industrial Average fell 0.91%, the Nasdaq Composite rose 0.10%, the S&P 500 fell 0.23%, and the German DAX fell 4.13%. Today, the Hang Seng Index rose 1.51% and the Hang Seng China Enterprises Index rose 2.31%. The top trading volume cross-border ETFs were ChinaAMC Hang Seng Tech ETF (down 4.39% with a discount rate of 4.63%), Huatai-PineBridge CSOP Hang Seng Tech ETF (down 3.42% with a discount rate of 5.17%), and E Fund CSI Overseas Internet ETF (down 3.13% with a discount rate of -12.18%) [16]. 7. Money Market ETFs - The top trading volume money market ETFs were Silver HuaRiLi ETF, HuaBao TianYi ETF, and CCB TianYi Money Market ETF [18].